Pms-pazopanib 200 Mg Tablet; Presence Of Sorafenib
Recall Summary PMS-Pazopanib 200 mg tablets are being recalled across Canada because they contain sorafenib, a different medication than what should be in the product. This is a Class I recall, indicating a serious quality issue. The recall affects all PMS-Pazopanib 200 mg tablets distributed in Canada.
- Product
- PMS-Pazopanib 200 mg tablet
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2023-05-31
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/58a88cc7-2df5-4e96-aed7-7ce3bfe0c090